| Symbol | CVRX |
|---|---|
| Name | CVRX, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 9201 WEST BROADWAY AVENUE,SUITE 650, MINNEAPOLIS, Minnesota, 55445, United States |
| Telephone | +1 763 416-2840 |
| Fax | — |
| — | |
| Website | https://www.cvrx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001235912 |
| Description | CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Additional info from NASDAQ: |
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
Read moreCVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
Read moreCVRx Announces Nomination of Michael Dale for Election to the Board of Directors
Read moreNew Form DEFA14A - CVRx, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001140361-26-015666 <b>Size:</b> 5 MB
Read moreNew Form DEF 14A - CVRx, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001140361-26-015657 <b>Size:</b> 3 MB
Read more(80% Positive) CVRX, INC. (CVRX) Announces Enrollment Update for programs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations
Read moreSecurities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Read moreSecurities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Read moreCVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07232030 | Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Fa… | Na | Heart Failure | Enrolling_By_Invitation | 2026-04-01 | 2033-01-01 | ClinicalTrials.gov |
| NCT07335510 | Impact of Barostimulation on Hemodynamics in Adults With Heart Failure | Na | HFrEF - Heart Failure With Reduced Ejection Fraction | Not_Yet_Recruiting | 2026-01-01 | 2028-03-01 | ClinicalTrials.gov |
| NCT06195046 | Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study | Na | Congestive Heart Failure | Withdrawn | 2025-07-01 | 2025-07-01 | ClinicalTrials.gov |
| NCT05860348 | Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level… | — | Heart Failure | Terminated | 2023-07-25 | 2024-12-11 | ClinicalTrials.gov |
| NCT04600791 | BATwire Implant Kit | Na | Heart Failure | Terminated | 2021-01-29 | 2025-02-17 | ClinicalTrials.gov |
| NCT04502316 | Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REB… | — | Heart Failure | Active_Not_Recruiting | 2020-06-26 | 2028-06-01 | ClinicalTrials.gov |
| NCT03730519 | UK Registry for Baroreflex Activation Therapy | Na | Baroreflex Failure Syndrome | Terminated | 2018-11-01 | 2021-11-01 | ClinicalTrials.gov |
| NCT02876042 | BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction | — | Heart Failure | Unknown | 2017-03-23 | 2024-07-01 | ClinicalTrials.gov |
| NCT02880631 | BAROSTIM THERAPY™ In Resistant Hypertension | — | Hypertension | Unknown | 2016-12-13 | 2024-07-01 | ClinicalTrials.gov |
| NCT02880618 | BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction | — | Heart Failure | Unknown | 2016-12-13 | 2024-07-01 | ClinicalTrials.gov |
| NCT02627196 | Baroreflex Activation Therapy for Heart Failure | Na | Heart Failure | Completed | 2016-04-19 | 2023-10-01 | ClinicalTrials.gov |
| NCT02210923 | Effect Baroreflex Activation Therapy on the Carotid Body | — | Hypertension Resistant To Conventional Therapy | Unknown | 2013-10-01 | — | ClinicalTrials.gov |
| NCT01679132 | BAROSTIM NEO Hypertension Pivotal Trial | Na | Uncontrolled Hypertension | Suspended | 2013-04-12 | 2026-03-01 | ClinicalTrials.gov |
| NCT01720160 | BAROSTIM® Hope for Heart Failure Study | Na | Heart Failure | Unknown | 2012-11-01 | 2021-03-01 | ClinicalTrials.gov |
| NCT01484288 | Baroreflex Activation Therapy in Heart Failure | Na | Heart Failure | Completed | 2011-11-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01471860 | BAROSTIM NEO System in the Treatment of Heart Failure | Na | Heart Failure | Unknown | 2011-08-01 | 2021-08-11 | ClinicalTrials.gov |
| NCT01471834 | Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treat… | Na | High Blood Pressure | Active_Not_Recruiting | 2011-06-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT00957073 | Rheos System for the Treatment of HFpEF Heart Failure | Na | Heart Failure | Completed | 2009-08-01 | 2021-04-01 | ClinicalTrials.gov |
| NCT00718939 | Rheos® Diastolic Heart Failure Trial | Na | Diastolic Heart Failure | Completed | 2008-07-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00442286 | Rheos® Pivotal Trial | Na | Hypertension | Completed | 2006-10-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT00710294 | Device Based Therapy in Hypertension Extension Trial | Na | Hypertension | Completed | 2005-08-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01077180 | Rheos Feasibility Trial | Phase2 | Hypertension | Completed | 2005-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00710190 | Device Based Therapy in Hypertension Trial | Na | Hypertension | Completed | 2003-07-01 | 2011-10-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Medical Management | Other | Approved | Heart Failure | UNKNOWN | NCT01471860 |
| BAROSTIM NEO System | Other | Approved | Heart Failure | UNKNOWN | NCT01471860 |
| BATwire Implant Kit | Other | Approved | Heart Failure | TERMINATED | NCT04600791 |
| Standard of care medical managment therapy for heart failure | Drug | Approved | Heart Failure | UNKNOWN | NCT01720160 |
| BAROSTIM NEO® System | Other | Approved | Heart Failure | UNKNOWN | NCT01720160 |
| Standard of care medical management | Other | Phase PHASE2 | Hypertension | COMPLETED | NCT01077180 |
| Implantation of the Rheos System | Other | Phase PHASE2 | Hypertension | COMPLETED | NCT01077180 |
| Barostim Neo System | Other | Approved | Heart Failure | COMPLETED | NCT01484288 |
| BAROSTIM NEO™ System | Other | Preclinical | Hypertension | UNKNOWN | NCT02880631 |
| Barostim Neo™ System | Other | Preclinical | Heart Failure | UNKNOWN | NCT02880618 |
| BAROSTIM NEO™ System | Other | Preclinical | Heart Failure | UNKNOWN | NCT02876042 |
| Baroreflex Activation Therapy with Barostim Neo | Drug | Approved | Baroreflex Failure Syndrome | TERMINATED | NCT03730519 |
| Barostim™ System | Other | Preclinical | Heart Failure | TERMINATED | NCT05860348 |
| BAROSTIM NEO System and Medical Management | Other | Approved | Uncontrolled Hypertension | SUSPENDED | NCT01679132 |
| Medical Management | Other | Approved | High Blood Pressure | ACTIVE_NOT_RECRUITING | NCT01471834 |
| BAROSTIM NEO System | Other | Approved | High Blood Pressure | ACTIVE_NOT_RECRUITING | NCT01471834 |
| Baroreflex Activation Therapy (BAT) | Drug | Approved | Congestive Heart Failure | WITHDRAWN | NCT06195046 |
| Baroreflex Activation Therapy | Drug | Approved | HFrEF - Heart Failure With Reduced Ejection Fraction | NOT_YET_RECRUITING | NCT07335510 |
| Medical Management | Other | Approved | Heart Failure | COMPLETED | NCT02627196 |
| BAROSTIM NEO® System | Other | Approved | Heart Failure | COMPLETED | NCT02627196 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | ENROLLING_BY_INVITATION | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Usual care medical management | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | Other | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim™ System | Other | Preclinical | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04502316 |
| Baroreflex Activation Therapy | DEVICE | Approved | HFrEF - Heart Failure With Reduced Ejection Fraction | NOT_YET_RECRUITING | NCT07335510 |
| Usual care medical management | OTHER | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Barostim System | DEVICE | Approved | Heart Failure | RECRUITING | NCT07232030 |
| Baroreflex Activation Therapy (BAT) | DEVICE | Approved | Congestive Heart Failure | WITHDRAWN | NCT06195046 |
| BATwire Implant Kit | DEVICE | Approved | Heart Failure | TERMINATED | NCT04600791 |
| Barostim™ System | DEVICE | Preclinical | Heart Failure | TERMINATED | NCT05860348 |
| Baroreflex Activation Therapy with Barostim Neo | DEVICE | Approved | Baroreflex Failure Syndrome | TERMINATED | NCT03730519 |
| Barostim Neo™ System | DEVICE | Preclinical | Heart Failure | UNKNOWN | NCT02880618 |
| BAROSTIM NEO™ System | DEVICE | Preclinical | Hypertension | UNKNOWN | NCT02880631 |
| Standard of care medical managment therapy for heart failure | OTHER | Approved | Heart Failure | UNKNOWN | NCT01720160 |
| BAROSTIM NEO® System | DEVICE | Approved | Heart Failure | COMPLETED | NCT02627196 |
| BAROSTIM NEO System and Medical Management | DEVICE | Approved | Uncontrolled Hypertension | SUSPENDED | NCT01679132 |
| Barostim Neo System | DEVICE | Approved | Heart Failure | COMPLETED | NCT01484288 |
| Medical Management | DRUG | Approved | Heart Failure | COMPLETED | NCT02627196 |
| BAROSTIM NEO System | DEVICE | Approved | Heart Failure | UNKNOWN | NCT01471860 |
| CVRx Rheos Baroreflex Hypertension Therapy System | DEVICE | Approved | Hypertension | COMPLETED | NCT00710294 |
| Standard of care medical management | OTHER | Phase PHASE2 | Hypertension | COMPLETED | NCT01077180 |
| Implantation of the Rheos System | DEVICE | Phase PHASE2 | Hypertension | COMPLETED | NCT01077180 |
| Rheos® system | DEVICE | Approved | Heart Failure | COMPLETED | NCT00957073 |
| Rheos Baroreflex Activation Therapy System | DEVICE | Approved | Diastolic Heart Failure | COMPLETED | NCT00718939 |
| Rheos Baroreflex Hypertension Therapy System | DEVICE | Approved | Hypertension | COMPLETED | NCT00710190 |
| Rheos® Baroreflex Hypertension System | DEVICE | Approved | Hypertension | COMPLETED | NCT00442286 |